Reduced HIV-1 infectability of CDd4+ lymphocytes from exposed- uninfected individuals: Association with low expression of CCR5 and high production of β-chemokines

Virology

Volumn 244, Issue 1, 1998, Pages 66-73

  Paxton, William A ^a   Liu, Rong ^a   Kang, Stanley ^a   Wu, Lijun ^b   Gingeras, Thomas R ^c   Landau, Nathanial R ^a   MacKay, Charles R ^b   Koup, Richard A ^a  

^a ROCKEFELLER UNIVERSITY   (United States)

^b MILLENNIUM PHARMACEUTICALS INC   (United States)

^c Thermo Fisher Scientific   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ARTICLE; GENOTYPE; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; LYMPHOCYTE; LYMPHOCYTE SUBPOPULATION; NONHUMAN; PRIORITY JOURNAL; VIRUS INFECTIVITY; VIRUS REPLICATION; VIRUS TRANSMISSION;

HUMAN IMMUNODEFICIENCY VIRUS; HUMAN IMMUNODEFICIENCY VIRUS 1; RNA VIRUSES;

EID: 0032565314     PISSN: 00426822     EISSN: None     Source Type: Journal    
DOI: 10.1006/viro.1998.9082     Document Type: Article

References (26)

1. Alkhatib G., Combadiere C., Broder C. C., Feng Y., Kennedy P. E., Murphy P. M., Berger E. A. CC CKR5: A RANTES, MIP-1α, MIP-1β receptor as a fusion cofactor for macrophage-tropic HIV-1. Science. 272:1996;1955-1958.
2. Biti R., French R., Young J., Bennetts B., Stewart G. HIV-1 infection in an individual homozygous for the CCR5 deletion allele. Nature Med. 3:1997;252-253.
3. Choe H., Farzan M., Sun Y., Sullivan N., Rollins B., Ponath P. D., Wu L., Mackay C. R., LaRosa G., Newman W., Gerard N., Gerard C., Sodroski J. The β-chemokine receptors CCR3 and CCR5 facilitate infection primary HIV-1 isolates. Cell. 85:1996;1135-1148.
4. +T-lymphocytes from two multiply exposed uninfected individuals resist infection with primary NSI isolates of human immunodeficiency virus type 1. J. Virol. 70:1996;8758-8764.
5. Connor R. I., Chen B. K., Choe S., Landau N. R. Vpr is required for efficient replication of human immunodeficiency virus type-1 in mononuclear phagocytes. Virology. 206:1995;935-944.
6. Dean M., Carrington M., Winkler C., Huttley G. A., Smith M. W., Allikmets R., Goedert J. J., Buchbinder S. P., Vittinghoff E., Donfield S., Vlahov D., Kaslow R., Saah A., Rinaldo C., Detels R., O'Brien S. J. Genetic restriction of HIV-1 infection and progression to AIDS by a deletion allele of the CKR5 structural gene. Science. 273:1996;1856-1862.
7. Deng H., Liu R., Ellmier W., Choe S., Unutmaz D., Burkhart M., DiMarzio P., Marmon S., Sutton R. E., Hill C. M., Davis C. B., Peiper S. C., Schall T. J., Littman D. R., Landau N. R. Identification of a major co-receptor for primary isolates of HIV-1. Nature. 381:1996;661-666.
8. Doranz B. J., Rucker J., Yanjie Y., Smyth R. J., Samson M., Peiper S. C., Parmentier M., Collman R. G., Doms R. W. A dual-tropic primary HIV-1 isolate that uses fusion and the β-chemokine receptors CKR-5, CKR-3, and CKR-2b as fusion cofactors. Cell. 85:1996;1149-1158.
9. Dragic T., Litwin V., Allaway G. P., Martin S. C., Huang Y., Nagashima K. A., Cayanan C., Maddon P. J., Koup R. A., Moore J. P., Paxton W. A. HIV-1 entry into CD4 cells is mediated by the chemokine receptor CC-CKR-5. Nature. 381:1996;667-673.
10. Endres M. J., Clapham P. R., Marsh M., Ahuja M., Turner J. D., McKnight A., Thomas J. F., Stoebenau-Haggarty B., Choe S., Vance P. J., Wells T. N. C., Power C. A., Sutterwala S. S., Doms R. W., Landau N. R., Hoxie J. A. CD4-independent infection by HIV-2 is mediated by fusin/CXCR4. Cell. 87:1996;745-756.
11. He J., Chen Y., Farzan F., Choe A., Ohagen A., Gartner S., Busciglio J., Yang X., Hofmann W., Newman W., Mackay C. R., Sodroski J., Gabuzda D. CCR3 and CCR5 are co-receptors for HIV-1 infection of microglia. Nature. 385:1997;645-649.
12. Huang Y., Paxton W. A., Wolinsky S. M., Neumann A. U., Zhang L., He T., Kang S., Ceradini D., Jin Z., Yazdanbakhsh K., Kunstman K., Erickson D., Dragon E., Landau N. R., Phair J., Ho D. D., Koup R. A. The role of a mutant CCR5 allele in HIV-1 transmission and disease progression. Nature Med. 2:1996;1240-1243.
13. Kozal M. J., Shah N., Shen N., Yang R., Fucini R., Merigan T. C., Richman D. D., Morris D., Hubbell E., Chee M., Gingeras T. R. Extensive polymorphisms observed in HIV-1 clade B protease gene using high-density oligonucleotide arrays. Nature Med. 2:1996;753-759.
14. Liu R., Paxton W. A., Choe S., Ceradini D., Martin S. R., Horuk R., MacDonald M. E., Stuhlmann H., Koup R. A., Landau N. R. Homozygous defect in HIV-1 co-receptor accounts for resistance of some multiply-exposed individuals to HIV-1 infection. Cell. 86:1996;367-377.
15. Michael N., Chang G., Louis L. G., Mascola J. R., Dondero D., Birx D. L., Sheppard H. W. The role of viral phenotype and CCR-5 gene defects in HIV-1 transmission and disease progression. Nature Med. 3:1997;338-340.
16. O'Brien T. R., Winkler C., Dean M., Nelson J. A., Carrington M., Michael N. L., White G. C. HIV-1 infection in a man homozygous for CCR5 Δ32. Lancet. 349:1997;1219.
17. Paxton W. A., Koup R. A. Mechanisms of resistance to HIV infection. Springer Semin. Immunopathol. 18:1996;323-340.
18. Paxton W. A., Martin S. R., Tse D., O'Brien T. R., Skurnick J., VanDevanter N. L., Padian N., Braun J. F., Kotler D. P., Wolinsky S. M., Koup R. A. Relative resistance to HIV-1 infection of CD4 lymphocytes from persons who remain uninfected despite multiple high-risk sexual exposures. Nature Med. 2:1996;412-417.
19. Samson M., Labbe O., Mollereau C., Vassart G., Parmentier M. Molecular cloning and functional expression of a new human CC-chemokine receptor gene. Biochemistry. 35:1996a;3362-3367.
20. Samson M., Libert F., Doranz B. J., Rucker J., Liesnard C., Farber C.-M., Saragosti S., Lapoumeroulie C., Cognzux J., Forceille C., Muyldermans G., Verhofstede C., Burtonboy G., Georges M., Imai T., Rana S., Yi Y., Smyth R. J., Collman R. G., Doms R. W., Vassart G., Parmentier M. Resistance to HIV-1 infection in Caucasian individuals bearing mutant alleles of the CCR-5 chemokine receptor gene. Nature. 382:1996b;722-725.
21. Smith M. W., Dean M., Carrington M., Winkler C., Huttley G. A., Lomb D. A., Goedert J. J., O'Brien T. R., Jacobson L. P., Kaslow R., Buchbinder S., Vittinghoff E., Vlahov D., Hoots K., Hilgartner M. W. Contrasting genetic influence of CCR2 and CCR5 variants on HIV-1 infection and disease progression. Science. 277:1997;959-965.
22. Theodorou I., Meyer L., Magierowska M., Katlama C., Rouzioux C. HIV-1 infection in an individual homozygous for CCR5 Δ32. Lancet. 349:1997;1219-1220.
23. Winkler C., Modi W., Smith M. W., Nelson G. W., Wu X., Carrington M., Dean M., Honjo T., Tashiro K., Yabe D., Buchbinder S., Vittinghoff E., Goedert J. J., O'Brien T. R., Jacobson L. P., Detels R., Donfield S., Willoughby A., Gomperts E., Vlahov D., Phair J. Genetic restriction of AIDS pathogenesis by an SDF-1 chemokine gene variant. Science. 279:1998;389-393.
24. Wu L., Paxton W. A., Kassam N., Ruffing N., Rottman J., Sullivan N., Choe H., Sodroski J., Newman W., Koup R. A., Mackay C. R. CCR5 levels and expression pattern correlate with infectability by macrophage-tropic HIV-1, in vitro. J. Exp. Med. 185:1997a;1681-1691.
25. Wu L., LaRosa G., Kassam N., Gordon C. J., Heath H., Ruffing N., Chen H., Humblias J., Samson M., Parmentier M., Moore J. P., Mackay C. R. Interaction of chemokine receptor CCR5 with its ligands: Multiple domains for HIV-1 gp120 binding and a single domain for chemokine binding. J. Exp. Med. 185:1997b;1373-1381.
26. Zimmerman P. A., Buckler-White A., Alkhatib G., Spalding T., Kubofcik J., Combadiere C., Weissman D., Cohen O., Rubbert A., Lam G., Vaccarezza M., Kennedy P. E., Kumaraswami V., Giorgi J. V., Detels R., Hunter J., Chopek M., Berger E. A., Fauci A. S., Nutman T. B., Murphy P. M. Inherited resistance to HIV-1 conferred by an inactivating mutation in CC chemokine receptor 5: Studies in populations with contrasting clinical phenotypes, defined racial background, and quantified risk. Mol. Med. 3:1997;23-36.